Ciprocopan succinate (development codes: HSK39297 and NXP100) is an innovative, oral small-molecule Complement Factor B (CFB) inhibitor. It is the world's first once-daily oral CFB inhibitor approved for medical use.
Ciprocopan succinate (development codes: HSK39297 and NXP100) is an innovative, oral small-molecule Complement Factor B (CFB) inhibitor. It is the world's first once-daily oral CFB inhibitor approved for medical use.